Literature DB >> 5090248

Reproducible polyarthritis in rats caused by Mycoplasma arthritidis.

P C Hannan, B O Hughes.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5090248      PMCID: PMC1005775          DOI: 10.1136/ard.30.3.316

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  MYCOPLASMA SPECIES IDENTIFICATION BASED UPON GROWTH INHIBITION BY SPECIFIC ANTISERA.

Authors:  W A CLYDE
Journal:  J Immunol       Date:  1964-06       Impact factor: 5.422

2.  The pathogenesis of mycoplasma (PPLO) arthritis in rats.

Authors:  J R WARD; R S JONES
Journal:  Arthritis Rheum       Date:  1962-04

3.  Experimental polyarthritis in rats injected with a tumour exudate.

Authors:  G JASMIN
Journal:  Ann Rheum Dis       Date:  1957-09       Impact factor: 19.103

4.  Effect of Animal Passage on Arthritogenic and Biological Properties of Mycoplasma arthritidis.

Authors:  L Golightly-Rowland; B C Cole; J R Ward; B B Wiley
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

5.  Arthritis in rats produced by pleuro-pneumonia-like organisms.

Authors:  M W PARKES; F WRIGLEY; B O'BRIEN
Journal:  Ann Rheum Dis       Date:  1951-06       Impact factor: 19.103

6.  Importance of extension and standardization of laboratory tests for the identification and classification of mycoplasma.

Authors:  J Fabricant; E A Freundt
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

7.  Haemadsorption and haemagglutination by mycoplasmas.

Authors:  R J Manchee; D Taylor-Robinson
Journal:  J Gen Microbiol       Date:  1968-03

8.  A comparative study on the virulence of Mycoplasma arthritidis and "Mycoplasma hominis, type 2" strains in rats.

Authors:  B C Cole; M L Miller; J R Ward
Journal:  Proc Soc Exp Biol Med       Date:  1967-01
  8 in total
  8 in total

1.  Comparison of four Mycoplasma arthritidis strains by enzyme immunoassay, metabolism inhibition, one- and two-dimensional electrophoresis, and immunoblotting.

Authors:  L R Washburn; S Hirsch
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Protection of rats against Mycoplasma arthritidis-induced arthritis by active and passive immunizations with two surface antigens.

Authors:  L R Washburn; E J Weaver
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Inhibition of mycoplasma-induced lymphocyte activation by sodium aurothiomalate.

Authors:  Y Naot; S Merchav
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

4.  Immunologic reactions of rabbit anti-Mycoplasma arthritidis serum with in vitro cultivated rat synovial cells.

Authors:  C E Thirkill; H G Muchmore; R M Hyde; L V Scott
Journal:  In Vitro       Date:  1981-05

5.  Association of lysogenic bacteriophage MAV1 with virulence of Mycoplasma arthritidis.

Authors:  L L Voelker; K E Weaver; L J Ehle; L R Washburn
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Effects of salicylates on blood changes in mycoplasma arthritis in rats.

Authors:  V Eisen; C Loveday
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

7.  Mechanisms of attachment of Mycoplasma arthritidis to host cells in vitro.

Authors:  L R Washburn; S Hirsch; L L Voelker
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

8.  Comparison of Mycoplasma arthritidis strains by enzyme-linked immunosorbent assay, immunoblotting, and DNA restriction analysis.

Authors:  L R Washburn; L L Voelker; L J Ehle; S Hirsch; C Dutenhofer; K Olson; B Beck
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.